Issue 19, 2023

NIR luminogen for low-temperature photothermal therapy by triggering HSP90α down-regulation

Abstract

A near-infrared (NIR) luminogen TST was designed and used to efficiently trigger HSP90α protein knockdown through photo-thermal conversion based on a gene interference strategy, by which in vitro and in vivo tumor ablation were significantly acquired at low-temperature.

Graphical abstract: NIR luminogen for low-temperature photothermal therapy by triggering HSP90α down-regulation

Supplementary files

Article information

Article type
Communication
Submitted
20 Dec. 2022
Accepted
27 Janv. 2023
First published
30 Janv. 2023

Chem. Commun., 2023,59, 2743-2746

NIR luminogen for low-temperature photothermal therapy by triggering HSP90α down-regulation

X. Yang, K. Ding, G. Zhang, P. Han, R. Hu, Z. Wang, A. Qin and B. Z. Tang, Chem. Commun., 2023, 59, 2743 DOI: 10.1039/D2CC06932F

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements